Abstract
THIS REPORT WILL:
- Provide an in-depth review of the global market for antibiotics resistance
and antibiotics technologies
- Offer an analysis of antibiotics resistance from an historical vantage
point
- Measure the current global market for antibiotics resistance and
antibiotics technologies and provide market data for 2008, estimates for 2009,
and compound annual growth rates (CAGRs) through 2014
- Describe various products by classes, including penicillins and
cephalsporins
- Profile key players in the antibiotics market
- Looks at government regulations adopted in various markets to combat
antibiotics resistance.
SCOPE OF REPORT
The scope of this report includes current antibiotic markets as well as the
emerging antibiotic market, with an exclusive focus on antibiotic resistance.
It technically encompasses antibacterials that include antibiotics, bacterial
vaccines, and other emerging antibacterials that are not necessarily
classified as antibiotics. Prevention of bacterial infections using bacterial
vaccines is within the scope of the study. Antiviral and antifungal products
are excluded from the market definition, and vaccines targeting viral diseases
are outside the scope of this study. In short, this report contains: Overview
of antibiotic market Classification of bacteria Classification of antibiotics
Mechanisms of resistance by bacteria Resistance trends and geographic analysis
Antibiotics targeted to counter the resistance mechanisms Emerging regulatory
trends Technology trends in combating resistance Patent analysis Current
antibiotic market and future growth trends Emerging new approaches and product
candidates in antibiotic resistance Analysis of leading companies and their
strategies Sales projections through 2014 for antibiotic resistance markets
The base year of this study is 2009. Market figures are based on the revenues
at the supplier levels, which are projected in 2009 constant dollars (i.e.,
inflation is not computed into the projection figures). The revenue figures
are derived from the revenues of the key players in a particular year.
Revenues of generic products are outside the scope of this study. Projections
for the antibiotic resistance market are based on the assumption that the new
and emerging products combat the antibiotic resistance issue in one way or
another. Hence, forecasts are for the antibiotic resistance markets and are
based mainly on the projections of the marketers.
INFORMATION SOURCES AND METHODOLOGY
Both primary and secondary research methods were used in this market research
study. The information and analysis presented in this report are based on an
extensive survey of the antibacterial sector as well as a detailed examination
of published literature and reports obtained from regulatory authorities,
research institutions, trade associations, and national and international
healthcare organizations. Key information from the literature was used to
obtain expert opinion on commercial potential and market sizes from industry
professionals. Data to prepare this study were derived from regulatory
agencies, annual reports of companies, scientific associations, public
healthcare authority websites, and industry related databases. In addition,
discussion with researchers and sales personnel of drug companies, academic
researchers, and government agency spokespersons have been conducted to gain
insight into the emerging market trends.
ANANLYST' S CREDENTIALS
Syamala Ariyanchira is a bench scientist who transferred to industry analysis.
She combines her technical background with business sector issues and is
involved in various activities, including technology assessment, strategic
planning, competitor analysis, due diligence, and market analysis. Her clients
include investment firms, government agencies, and chemical and pharmaceutical
companies. She holds a PhD from Indian Institute of Science, Bangalore, India,
and has authored three recent reports for BCC Research.
| 
View Cart
